Metagenomics Sequencing Market is
anticipated to witness impressive growth during the forecast period. This can be ascribed to the
growing awareness about genetic disorders due to genetic history along with
growing demand for advanced bioinformatics tools. Also, growing development of
novel drugs and high throughput screening methods along with cost effective
technologies developments are expected to create lucrative growth during the
forecast period. Similarly, rise in research and development activities for
identifying newer antibiotics and enzymes is a major factor fueling the growth
of market over the upcoming years. For instance, in August 2022, OpGen,
Inc., a personalized medicine company, announced to launch next-generation
sequencing (NGS) services under the subsidiary, Ares Genetics.
Growing
demand for personalized medicine
Personalized
medicine is a key driver for the growth of the Global Metagenomics Sequencing
Market. Personalized medicine aims to provide targeted therapies and treatments
that are tailored to the individual patient based on their specific genetic
makeup and environmental factors. Metagenomics sequencing provides a powerful
tool for understanding the composition and function of microbes which are present
in our body, can be used to develop therapies for the chronic diseases.
Metagenomics sequencing can be used to identify the
specific microbes present in a patient's gut, skin, or other body sites, and
determine how these microbes are interacting with the patient's immune system
and other physiological systems. This information is generally used to
develop therapies that can modulate the patient’s microbiome for treating the
conditions such as cancer, diabetes, inflammatory bowel disease.
In addition, metagenomics sequencing can be used to
identify the specific pathogens that are causing an infectious disease, and to
determine the most effective treatments for those pathogens. This can help to
reduce the use of broad-spectrum antibiotics and other treatments that can lead
to the development of antibiotic resistance.
Advancements
in sequencing technologies
Advancements
in sequencing technologies have had a significant impact on the growth of the Global
Metagenomics Sequencing Market. Next-generation sequencing and single-molecule
sequencing technologies have greatly enhanced the throughput, accuracy, and
speed of metagenomics sequencing, making it more accessible to a wider range of
users, including researchers and clinicians. These
advancements have led to the development of new bioinformatics tools and software
that can more effectively analyze the vast amounts of data generated by
metagenomics sequencing. These tools help researchers and clinicians to extract
more meaningful insights from metagenomics data, and develop new diagnostic and
therapeutic applications. In addition, the development of
portable sequencing technologies is enabling metagenomics sequencing to be
performed in field settings, making it possible to study microbial communities
in remote or resource-limited areas. This is opening new opportunities for
environmental monitoring, public health, and agriculture applications.
As sequencing technologies continue to advance, the
cost of metagenomics sequencing is expected to continue to decline, making it
more accessible to researchers and clinicians around the world. This is
expected to drive the growth of the global metagenomics sequencing market, as
the technology becomes more widely adopted in a range of research, clinical,
and commercial applications.
Increasing
need for environmental monitoring and management
Environmental
monitoring and management are important drivers of the growth of the Global
Metagenomics Sequencing Market. Metagenomics sequencing can be used to study
microbial communities in a wide range of environments, including soil, water,
air, and the built environment. This information can be used to better
understand the ecology and function of these communities, and to develop more
effective strategies for environmental management and remediation.
Particularly,
metagenomics sequencing can be used to identify and monitor microbial
indicators of environmental health, such as pathogenic bacteria, fungi, and
viruses. This can be important for identifying and managing outbreaks of
infectious diseases in human and animal populations, and for monitoring the
health of ecosystems and natural resources. In
addition, metagenomics sequencing can be used to study the impact of
environmental stressors, such as pollution and climate change, on microbial
communities and their functions. The growing demand for environmental
monitoring and management is driving the development of new metagenomics
sequencing technologies and analytical tools that are better suited to these applications.
Rising
demand for precision agriculture
Precision
agriculture is a key driver for the growth of the global metagenomics
sequencing market. Precision agriculture is a farming technique that uses
data-driven approaches to optimize crop production and reduce environmental
impact. Metagenomics sequencing can be used to study the microbial communities
that live in the soil and on plants, and to better understand the interactions
between these communities about plant health and growth.
By studying the microbial communities in the soil and
on plants, farmers can gain a better understanding of the nutrient and water
requirements of crops, as well as their susceptibility to pests and diseases.
This information can be used to develop more targeted fertilization,
irrigation, and pest management strategies, leading to increased crop yields
and reduced environmental impact.
Metagenomics
sequencing can also be used to study the diversity of soil microbial
communities and their functional roles in soil processes such as nutrient
cycling, carbon sequestration, and soil aggregation. This information can be
used to develop new strategies for sustainable agriculture that promote soil
health and resilience, while also reducing the use of synthetic fertilizers and
pesticides. As precision agriculture
continues to gain traction, the demand for metagenomics sequencing is expected
to increase, driving the development of new technologies and analytical tools
that are better suited to these applications. Further, expected to drive the
growth of the Global Metagenomics Sequencing Market, as farmers, researchers,
and agribusinesses adopt metagenomics sequencing to optimize crop production
and improve sustainability.
Growing
availability of funding for genomics research
Government
funding for genomic research has played a critical role in the growth of the Global
Metagenomics Sequencing Market. Genomic research is expensive and requires
significant investment in equipment, infrastructure, and personnel. Government
funding can help to provide the necessary resources to support research and
development in the field of metagenomics sequencing.
Government
funding has supported the development of new sequencing technologies,
bioinformatics tools, and data analysis methods, which have greatly enhanced
the accuracy and speed of metagenomics sequencing. This has made it possible to
sequence larger and more complex samples, which has led to new insights into
the diversity and function of microbial communities in a range of environments.
Government funding has also supported the translation
of metagenomics research into clinical and commercial applications. For
example, government funding has supported the development of metagenomics-based
diagnostic tests for infectious diseases and cancer, as well as the development
of new drugs and therapies based on insights gained from metagenomics research.
In
addition to funding research and development, government funding can help to
create a favorable policy environment for the adoption of metagenomics
sequencing in research and clinical settings. This can include regulations that
promote the use of genomic data in medical practice and research, as well as
initiatives that promote the sharing of genomic data across different research
groups.
Download Free Sample Report
Recent Development
· Oxford Nanopore
PromethION: Oxford Nanopore launched the PromethION sequencing platform in
2018, which is a portable and scalable system for real-time sequencing of long
DNA fragments. The platform can be used for a wide range of applications,
including metagenomics sequencing.
· QIAGEN Microbial
Insights ARB: QIAGEN launched the Microbial Insights ARB in 2020, which is a
metagenomics analysis software that enables researchers to study microbial
communities and their functions in various environments. The software uses a
database of annotated microbial genomes to provide accurate taxonomic and
functional analysis of metagenomic data.
· BGI One-Stop
Microbiome Sequencing Service: In 2022, BGI launched its One-Stop Microbiome
Sequencing Service, which is a comprehensive service for analyzing microbiome
samples using metagenomics sequencing. The service includes sample preparation,
sequencing, and data analysis, and is designed for a wide range of
applications, including medical and environmental research.
· PacBio Sequel
IIe System: PacBio launched the Sequel IIe System in 2021, which is a
high-throughput, long-read sequencing platform that can generate up to 10
terabases of data in a single run. The system is designed for a wide range of
applications, including metagenomics sequencing.
· Illumina DRAGEN
Metagenomics Pipeline: In 2021, Illumina launched its DRAGEN Metagenomics
Pipeline, which is a software solution for analyzing metagenomics sequencing
data. The pipeline uses advanced algorithms and machine learning techniques to
provide accurate taxonomic and functional analysis of microbial communities.
Market Segmentation
Global Metagenomics
Sequencing Market can be segmented by product and service, technology, application,
and by region. Based on the product and service, the market can be segmented into reagents & consumables, instruments, and
services. Based on technology, the market can be segmented into shotgun metagenomic sequencing, 16S rRNA
sequencing, whole genome sequencing & de novo assembly, and meta
transcriptomics. Based on application, the market can be differentiated into
drug discovery, ecological & environmental metagenomics, clinical
diagnostics, biofuel, and industrial applications.
Market Players
BGI Genomics Co Ltd., Eurofins
Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies
Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V.,
Swift Biosciences Inc., Thermo Fisher
Scientific Inc. are some of the leading players
operating in the Global Metagenomics Sequencing Market.
Attribute
|
Details
|
Base
Year
|
2022
|
Historic
Data
|
2018 –
2021
|
Estimated
Year
|
2023
|
Forecast
Period
|
2024
– 2028
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments
Covered
|
By Product and Service
By Technology
By Application
By Region
|
Regional
scope
|
North
America; Europe; Asia Pacific; South America; Middle East & Africa
|
Country
scope
|
United States; Canada; Mexico; France; Germany; United
Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina;
Colombia; South Africa; Saudi Arabia; UAE
|
Key
companies profiled
|
BGI
Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc.,
Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc.,
Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher
Scientific Inc.
|
Customization
scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
Pricing
and purchase options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
Delivery
Format
|
PDF and Excel through
Email (We can also provide the editable version of the report in PPT/Word format
on special request)
|
Report Scope:
In this report, Global Metagenomics
Sequencing market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- Metagenomics
Sequencing Market, By Product and Service:
- Reagents
& consumables
- Instruments
- Services
- Metagenomics
Sequencing Market, By Technology:
- Shotgun
metagenomic sequencing
- 16S rRNA
sequencing
- Whole
genome sequencing & de novo assembly
- Meta
transcriptomics
- Metagenomics
Sequencing Market, By Application:
- Drug
discovery
- Ecological
& environmental metagenomics
- Clinical
diagnostics
- Biofuel
- Industrial
applications
- Metagenomics
Sequencing Market, By Region:
- North
America
- United
States
- Canada
- Mexico
- Europe
- France
- Germany
- United
Kingdom
- Italy
- Spain
- Asia
Pacific
- China
- India
- Japan
- South
Korea
- Australia
- South
America
- Brazil
- Argentina
- Colombia
- Middle
East & Africa
- South
Africa
- Saudi
Arabia
- UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Global Metagenomics Sequencing Market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
Global Metagenomics
Sequencing Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]